drugset
drugset / Trial / NCT01888497

Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers

NCT01888497 ↗

Phase 3 Completed 59 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

This study will examine the next-day residual effects of a nighttime dose of gabapentin 250 mg, diphenhydramine citrate 76 mg and triazolam 0.5 mg compared to placebo and each other on simulated driving performance in normal volunteer subjects. It will also examine other measures of next-day performance and next-day sleepiness.

Timeline

Start
2013-07-29
Primary completion
2013-12-14
Completion
2013-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 76 mg Oral
Subject Gabapentin Small molecule 250 mg Oral
Comparator Triazolam Small molecule 0.5 mg Oral

Indications

No indication recorded.